评估莱夫卢诺米德和甲甲酸组合与单疗法在类风湿性关节炎和牛皮性关节炎
Mete Kara1, Gülay Alp2, Mete Pekdiker3
1Department of Rheumatology, İzmir City Hospital, İzmir, Turkiye.
Turkish journal of medical sciences
|July 21, 2025
概括
结合甲状腺素 (MTX) 和 leflunomide (LEF) 为风湿性关节炎 (RA) 和牛皮性关节炎 (PsA) 提供了安全有效的治疗方法. 这种组合疗法显示出更好的疗效,减少了对其他先进治疗的需求.
科学领域:
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 甲托雷克萨特 (MTX) 和莱夫卢诺米德 (LEF) 是常见的修改疾病的抗风湿药物 (DMARD) 用于类风湿性关节炎 (RA) 和牛皮性关节炎 (PsA).
- 这些药物作为单一疗法或组合使用,具有不同的疗效和安全性.
研究的目的:
- 为了比较联合MTX加LEF治疗与RA和PSA患者单一治疗的不良反应 (AE) 和疗效.
- 在这些治疗方案下确定RA和PsA患者低疾病活性 (LDA) 的预测因子.
主要方法:
- 一项涉及528名患者 (385名RA,143名PsA) 的研究,至少进行6个月的随访.
- 使用DAS-28 CRP和DAPSA评估疾病活动;使用MedDRA分类分类的AE.
- 统计分析包括单变量和多变量分析,以确定LDA的预测因素.
主要成果:
- 累计的AE发生率各不相同:RA (MTX 23.8%,LEF 28.2%,MTX+LEF 19.2%);PSA (MTX 18.1%,LEF 30%,MTX+LEF 23.3%). 这两种情况都存在.
- 与单疗法相比,MTX加LEF在RA和PSA中表现出疾病活性,葡萄糖皮质激素剂量和生物/向DMARDs (b/tsDMARDs) 使用的优异降低.
- 在RA中LDA的预测因素包括MTX剂量和初始DAS28-CRP;在PsA中,疾病持续时间是独立的预测因素.
结论:
- 结合治疗MTX加LEF是一种有价值,安全和有效的RA和PsA的替代方案.
- 这种组合在生物/向DMARD治疗不可行或具有挑战性时特别有用.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
236
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
236
Drug Therapy
103
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
103
Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K
Rheumatic Heart Disease III: Medical Management
33
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
33
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
203
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
203


